First AD

Second AD

Joshua K. Sabari, MD; Jamie Chaft, MD; and Vamsidhar Velcheti, MD, highlight the intriguing data in the realm of EGFR exon 21 insertion mutations in non–small cell lung cancer presented during the 2021 ASCO Annual Meeting.


The episode is part of the third series of Thoracic Night Live, a program devoted to spotlighting the biggest topics in lung cancer and pivotal studies discussed at medical meetings throughout the year. 

Thoracic Night Live

Thoracic Night Live is a hybrid video program devoted to spotlighting the biggest topics in lung cancer and pivotal studies discussed at medical meetings throughout the year. Episodes have focused data that were presented during the ASCO Annual Meeting, ESMO Congress, World Conference on Lung Cancer, and New York Lung Cancer Symposium, among other conferences.


Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

ASCO 2021: Game-Changing Data in Lung Cancer

Joshua K. Sabari, MD; Jamie Chaft, MD; and Vamsidhar Velcheti, MD, highlight the intriguing data in the realm of EGFR exon 21 insertion mutations in non–small cell lung cancer presented during the 2021 ASCO Annual Meeting. 


Enthusiasm With EGFR Exon 20+ in NSCLC